Catherine C. Fenselau, professor of chemistry and biochemistry at the University of Maryland, is the 2012 recipient of the Award for a Distinguished Contribution in Mass Spectrometry, granted by the American Society for Mass Spectrometry (ASMS). The award honors her pioneering work to apply mass spectrometry to the rapid identification and characterization of intact microorganisms.
Catherine C. Fenselau, professor of chemistry and biochemistry at the University of Maryland, is the 2012 recipient of the Award for a Distinguished Contribution in Mass Spectrometry, granted by the American Society for Mass Spectrometry (ASMS). The award honors her pioneering work to apply mass spectrometry to the rapid identification and characterization of intact microorganisms.
In 1975, Fenselau and J.P. Anhalt were the first to report that biomolecules from different pathogenic bacteria, introduced intact into a mass spectrometer, could be vaporized and directly ionized; could be structurally identified; and that the compositions and abundance of these chemical biomarkers, as revealed in mass spectra, allowed taxonomic distinctions. Fenselau’s pioneering approach of using intact molecular biomarkers for rapid microorganism characterization by mass spectrometry was in sharp contrast to concurrent research advocating vigorous pyrolysis before MS analysis.
In the following decade, Fenselau and her team were the first to evaluate newer ionization methods (such as laser desorption, plasma desorption, and fast atom bombardment) for the rapid MS analysis of nonvolatile biomarkers from intact bacterial cells. Further, her work in fingerprinting and in applying proteomic techniques for microorganisms laid the foundation for major developments in epidemiology to track and prevent disease from infectious diseases.
Currently, Fenselau is developing proteomic and bioinformatic strategies that allow rapid identification of bacteria, spores, protein toxins and viruses, with particular emphasis on characterization of genetically engineered bacteria, bacteria without sequenced genomes and bacteria in mixtures.
Hear Professor Fenselau’s award plenary talk today at 4:45 pm in Exhibit Hall A, on the exhibit level.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.